Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Department of Chest, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Egypt J Immunol. 2024 Jul;31(3):15-27.
The interleukin 13 (IL-13) gene single nucleotide polymorphisms (SNPs) are frequently linked to increased vulnerability to allergic asthma. Forkhead box protein P3 (FOXP3) is an important molecule in the formation of regulatory T cells (Treg). The genetic variants that alter FOXP3 function may have a role in the development of asthma and other allergic disorders. We aimed to determine the association of IL-13 rs20541, FOXP3 rs3761548 genes SNPs and serum levels of IL-13 with allergic asthma patients. In this case-control study, 41 Egyptian patients with allergic asthma were included. Age and gender matched. 41 normal volunteers were considered the controls. All subjects were examined for IL-13 rs20541 and FOXP3 rs3761548 SNPs by the polymerase chain reaction /restriction fragment length polymorphism technique. The serum level of IL-13 was assessed by the enzyme linked immunosorbent assay (ELISA). AA genotype at IL-13 rs20541 SNP was statistically significantly different between the studied groups (p= 0.042). Also, a statistically significant difference was detected when compared AA genotype to GG genotype as AA genotype was three times at risk for asthma (p1=0.031) (OR=3.95) and A allele increased the risk of asthma by about 3 times (OR=3.2). AA genotype at FOXP3 rs3761548 SNP was statistically significantly different between the studied groups (p=0.013). Also, a statistically significant difference was detected when compared AA genotype to CC genotype as AA genotype was 7 times at risk for asthma (p1=0.003) (OR=7.04) and A allele increased the risk of asthma by about 3 times (p<0.001) (OR=3.07). The serum level of IL-13 was statistically significant different between both groups (p<0.001). We can conclude that IL-13 could be a useful tool for predicting allergic asthma. Patients with AA genotype of IL-13 rs20541 and AA genotype of FOXP3 rs3761548 have a higher risk for developing allergic asthma.
白细胞介素 13(IL-13)基因单核苷酸多态性(SNP)与过敏性哮喘的易感性增加密切相关。叉头框蛋白 P3(FOXP3)是调节性 T 细胞(Treg)形成的重要分子。改变 FOXP3 功能的遗传变异可能在哮喘和其他过敏性疾病的发展中起作用。我们旨在确定 IL-13 rs20541、FOXP3 rs3761548 基因 SNPs 与过敏性哮喘患者的关系以及血清中 IL-13 的水平。在这项病例对照研究中,纳入了 41 例埃及过敏性哮喘患者。年龄和性别匹配。41 名正常志愿者被认为是对照组。所有受试者均通过聚合酶链反应/限制性片段长度多态性技术检测 IL-13 rs20541 和 FOXP3 rs3761548 SNP。通过酶联免疫吸附试验(ELISA)评估血清中 IL-13 的水平。IL-13 rs20541 SNP 的 AA 基因型在研究组之间存在统计学差异(p=0.042)。当比较 AA 基因型与 GG 基因型时,也发现了统计学差异,因为 AA 基因型患哮喘的风险增加了三倍(p1=0.031)(OR=3.95),A 等位基因使哮喘的风险增加了约三倍(OR=3.2)。FOXP3 rs3761548 SNP 的 AA 基因型在研究组之间存在统计学差异(p=0.013)。当比较 AA 基因型与 CC 基因型时,也发现了统计学差异,因为 AA 基因型患哮喘的风险增加了 7 倍(p1=0.003)(OR=7.04),A 等位基因使哮喘的风险增加了约 3 倍(p<0.001)(OR=3.07)。两组之间的血清 IL-13 水平存在统计学差异(p<0.001)。我们可以得出结论,IL-13 可能是预测过敏性哮喘的有用工具。IL-13 rs20541 的 AA 基因型和 FOXP3 rs3761548 的 AA 基因型的患者发生过敏性哮喘的风险更高。